Clinical trials
Phase 2 Triple Negative Breast Neoplasms trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
| Completed | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Ayala Pharmaceuticals, Inc, | 1 |
| Celldex Therapeutics | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| G1 Therapeutics, Inc. | 1 |
| Jules Bordet Institute | 1 |
| Sanofi | 1 |
| Synta Pharmaceuticals Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 14 |
| Breast Neoplasms | 5 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Head and Neck Neoplasms | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
| Pancreatic Neoplasms | 1 |
| Spinocerebellar Degenerations | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.